FDA approves Xifaxan for liver disease
Thursday, March 25, 2010 - 06:56
in Health & Medicine
WASHINGTON, March 25 (UPI) -- The U.S. Food and Drug Administration says it has approved Xifaxan for reducing the risk of overt hepatic encephalopathy recurrence in advanced liver disease.